IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital Management LP

Q1 2024 Holdings

Filed 2024-05-14 | 16 holdings | $295.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
BridgeBio Pharma Inc. (Bbio)(BBIO)COM10806X102$187.6M6,068,12563.5%
Syndax Pharmaceuticals, Inc. (Sndx)(SNDX)COM87164F105$24.4M1,025,0008.3%
Verona Pharma plc (Vrna)(VRNA)SPONSORED ADS925050106$17.9M1,115,3526.1%
Elevation Oncology Inc (Elev)COM28623U101$14.5M2,834,9104.9%
Biomea Fusion Inc (Bmea)(BMEA)COM09077A106$11.9M798,7574.0%
Monte Rosa Therapeutics Inc (Glue)(GLUE)COM61225M102$10.4M1,472,3313.5%
Nuvation Bio Inc. (Nuvb)(NUVB)COM CL A67080N101$9.2M2,541,0093.1%
Compass Pathways Plc (Cmps)(CMPS)SPONSORED ADS20451W101$8.0M964,5002.7%
Poseida Therapeutics Inc. (Pstx)(PSTXUSD)COM73730P108$3.3M1,043,2671.1%
CalciMedica, Inc. (Calc)(CALC)COM38942Q202$2.2M521,1140.7%
Reneo Pharmaceuticals Inc (Rphm)(RPHM)COM75974E103$1.5M886,0750.5%
Marker Therapeutics, Inc. (Mrkr)(MRKR)COM NEW57055L206$1.4M314,2860.5%
Avrobio, Inc. (Avro)COM05455M100$1.3M1,009,7790.4%
Spruce Biosciences, Inc. (Sprb)COM85209E109$947.5K1,205,5110.3%
Aclaris Therapeutics Inc (Acrs)(ACRS)COM00461U105$538.7K434,4550.2%
Viracta Therapeutics Inc (Virx)COM92765F108$294.3K288,5710.1%